Your browser doesn't support javascript.
loading
Impaired high-density lipoprotein function and endothelial barrier stability in severe anaphylaxis.
Fernandez-Bravo, Sergio; Canyelles, Marina; Martín-Blázquez, Ariadna; Borràs, Carla; Nuñez-Borque, Emilio; Palacio-García, Lucia; Rodríguez Del Rio, Pablo; Betancor, Diana; Gómez-López, Alicia; Sabaté Brescó, Marina; Laguna, José Julio; Méndez-Barbero, Nerea; Rotllan, Noemi; Escolà-Gil, Joan Carles; Esteban, Vanesa.
  • Fernandez-Bravo S; Department of Allergy and Immunology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
  • Canyelles M; Institut de Recerca de l'Hospital Santa Creu i Sant Pau, Institut d'Investigacions Biomèdiques Sant Pau, Barcelona, Spain; CIBER of Diabetes and Related Metabolic Diseases, Instituto de Salud Carlos III, Madrid, Spain.
  • Martín-Blázquez A; Department of Allergy and Immunology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
  • Borràs C; Institut de Recerca de l'Hospital Santa Creu i Sant Pau, Institut d'Investigacions Biomèdiques Sant Pau, Barcelona, Spain; CIBER of Diabetes and Related Metabolic Diseases, Instituto de Salud Carlos III, Madrid, Spain.
  • Nuñez-Borque E; Department of Allergy and Immunology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
  • Palacio-García L; Department of Allergy and Immunology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
  • Rodríguez Del Rio P; Allergy Department, Hospital Infantil Universitario Niño Jesús, Fundación HNJ, Health Research Institute-Princesa, Madrid, Spain.
  • Betancor D; Department of Allergy. Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (FJD, UAM), Madrid, Spain.
  • Gómez-López A; Department of Allergy. Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (FJD, UAM), Madrid, Spain.
  • Sabaté Brescó M; Department of Allergy and Clinic Immunology, Clínica Universidad de Navarra, and Red de Enfermedades Inflamatorias (RD21/0002/0028), Pamplona, Spain; Health Research Institute (IDISNA, Instituto de Investigación Sanitaria de Navarra), Pamplona, Spain.
  • Laguna JJ; Allergy Unit, Allergo-Anaesthesia Unit, Cruz Roja Central Hospital, and Red de Enfermedades Inflamatorias (RD21/0002/0008), Madrid, Spain.
  • Méndez-Barbero N; Vascular Pathology Research Laboratory, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain; Faculty of Medicine, Universidad Alfonso X el Sabio (UAX), Villanueva de la Cañada, Spain.
  • Rotllan N; Institut de Recerca de l'Hospital Santa Creu i Sant Pau, Institut d'Investigacions Biomèdiques Sant Pau, Barcelona, Spain; CIBER of Diabetes and Related Metabolic Diseases, Instituto de Salud Carlos III, Madrid, Spain.
  • Escolà-Gil JC; Institut de Recerca de l'Hospital Santa Creu i Sant Pau, Institut d'Investigacions Biomèdiques Sant Pau, Barcelona, Spain; CIBER of Diabetes and Related Metabolic Diseases, Instituto de Salud Carlos III, Madrid, Spain.
  • Esteban V; Department of Allergy and Immunology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain; Faculty of Medicine, Universidad Alfonso X el Sabio (UAX), Villanueva de la Cañada, Spain. Electronic address: vesteban@fjd.es.
J Allergy Clin Immunol ; 154(3): 827-832, 2024 Sep.
Article en En | MEDLINE | ID: mdl-38718948
ABSTRACT

BACKGROUND:

Growing evidence demonstrates the importance of high- and low-density lipoprotein cholesterol in certain immune and allergy-mediated diseases.

OBJECTIVE:

This study aimed to evaluate levels of high- and low-density lipoprotein cholesterol and apolipoproteins A1 and B in sera from a cohort of patients presenting with hypersensitivity reactions. We further assessed the function of high-density lipoprotein particles as well as their involvement in the molecular mechanisms of anaphylaxis.

METHODS:

Lipid profile determination was performed in paired (acute and baseline) serum samples from 153 patients. Thirty-eight experienced a non-anaphylactic reaction and 115 had an anaphylactic reaction (88 moderate and 27 severe). Lecithin cholesterol acyl transferase activity was assessed in patient sera, and we also evaluated macrophage cholesterol efflux in response to the serum samples. Last, the effect of anaphylactic-derived high-density lipoprotein (HDL) particles on the endothelial barrier was studied. Detailed methods are provided in the Methods section in this article's Online Repository available at www.jacionline.org.

RESULTS:

Serum samples from severe anaphylactic reactions show statistically significant low levels of HDL cholesterol, low-density lipoprotein cholesterol, and apolipoproteins A1 and B, which points to their possible role as biomarkers. Specifically, HDL particles play a protective role in cardiovascular diseases. Using functional human serum cell assays, we observed impaired capacity of apolipoprotein B-depleted serum to induce macrophage cholesterol efflux in severe anaphylactic reactions. In addition, purified HDL particles from human anaphylactic sera failed to stabilize and maintain the endothelial barrier.

CONCLUSION:

These results encourage further research on HDL functions in severe anaphylaxis, which may lead to new diagnostic and therapeutic strategies.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Apolipoproteína A-I / Anafilaxia Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Apolipoproteína A-I / Anafilaxia Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2024 Tipo del documento: Article